Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Oligodendroglioma 1Glioma 1Astrocytoma 1

Interventions

Surveys and Questionnaires 2Psychiatric Rehabilitation 2Magnetic Resonance Spectroscopy 2Amplified Fragment Length Polymorphism Analysis 2fluarix 1Tetanus Toxoid 1Temozolomide 1Radiotherapy 1Quality of Life 1Proton Magnetic Resonance Spectroscopy 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Mental Status and Dementia Tests 1Influenza Vaccines 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1Hepatitis A Vaccines 1FluLaval 1FluBlok 1Flow Cytometry 1Comparative Genomic Hybridization 1Climate Anxiety 1Anthropogenic Effects 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Oligodendroglioma × fluarix × Clear all
NCT02747407 2021-10-29

Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

Wake Forest University Health Sciences

Completed
55 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡